Search results
Results from the WOW.Com Content Network
Flipkart used aggressive discounts and focused on customer service to move towards a leadership position in the market. WeRead consisted of a large network of readers (~3 million) with around 60 million books. The platform also noted information that was user generated – such as people marking a book as favorite or leaving a review or rating.
In 2018, Bansal exited Flipkart following the Walmart deal. [6] In 2007, Sachin Bansal and Binny Bansal (not related) founded Flipkart whose valuation in 2018 was $20.8 billion. [7] In 2018, Bansal held a 5.5 per cent stake in Flipkart, which he sold to Walmart and his net worth then was a little over $1 billion. [7]
Binny Bansal (born 1982/1983) is an Indian billionaire [2] [3] Internet entrepreneur. [3] As of February 2024, his net worth was estimated at US$1.4 billion. [1] In 2007 he co-founded the e-commerce platform Flipkart.
Myntra continues to operate as a standalone brand under Flipkart's ownership, focusing primarily on "fashion-conscious" consumers. [ 14 ] In 2014, Myntra's portfolio included about 1,50,000 products of over 1,000 brands, with a distribution area of around 9,000 pincodes in India. [ 15 ]
WASHINGTON (Reuters) -The U.S. Justice Department filed a complaint and announced a civil enforcement action on Monday against financial technology company Dave and its CEO Jason Wilk for alleged ...
Flipkart introduced Shopsy in July 2021 [3] [4] as a mobile app that allowed people in India to launch their own online reseller business. [5] [6] [7] By August 2021, the app had adopted a zero-commission marketplace model. [8] [9] Later, Shopsy shifted its focus to become a B2C company. [10]
Back in 2022, Epic agreed to pay a total of $520 million to settle complaints revolving around children’s privacy and payment methods on its popular Fortnite game. The FTC also accused Epic of ...
In fact, though this rule of thumb has been around since the 1960s, there’s little *scientific* evidence that walking 10,000 steps should be your target, according to a 2022 review in The Lancet.